Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) EPS (Weighted Average and Diluted) (2016 - 2025)

SRx Health Solutions' EPS (Weighted Average and Diluted) history spans 14 years, with the latest figure at -$0.74 for Q2 2025.

  • For Q2 2025, EPS (Weighted Average and Diluted) fell 428.57% year-over-year to -$0.74; the TTM value through Sep 2025 reached -$1.03, up 80.61%, while the annual FY2025 figure was -$2.13, N/A changed from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.74 in Q2 2025 per SRXH's latest filing, down from -$0.37 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.19 in Q2 2021 to a low of -$58.42 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$5.34, with a median of -$0.3 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 152.65% in 2021, then crashed 29110.0% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.2 in 2021, then plummeted by 29110.0% to -$58.42 in 2022, then skyrocketed by 64.32% to -$20.85 in 2023, then skyrocketed by 99.18% to -$0.17 in 2024, then plummeted by 335.29% to -$0.74 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's EPS (Weighted Average and Diluted) are -$0.74 (Q2 2025), -$0.37 (Q1 2025), and -$0.17 (Q4 2024).